Zynex Newsroom

RBC Capital Maintains Zynex(ZYXI.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsOct 25 08:36 ET

Zynex Analyst Ratings

BenzingaOct 25 07:18 ET

H.C. Wainwright Maintains Zynex(ZYXI.US) With Buy Rating, Raises Target Price to $17

Moomoo NewsOct 25 06:34 ET

Zynex's Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating

TipRanksOct 25 06:20 ET

Zynex Is Maintained at Outperform by RBC Capital

Dow JonesOct 8 15:09 ET

RBC Capital Maintains Zynex(ZYXI.US) With Buy Rating, Cuts Target Price to $11

Moomoo NewsOct 8 08:31 ET

Northland Securities Initiates Zynex(ZYXI.US) With Buy Rating, Announces Target Price $12.5

Moomoo NewsSep 17 20:31 ET

Zynex Analyst Ratings

BenzingaSep 4 13:10 ET

H.C. Wainwright Maintains Zynex(ZYXI.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsSep 4 11:31 ET

Buy Rating Affirmed for Zynex on FDA Clearance and Solid Growth Prospects

TipRanksSep 4 11:07 ET

Zynex Analyst Ratings

BenzingaJul 26 07:56 ET

RBC Capital Maintains Zynex(ZYXI.US) With Buy Rating, Cuts Target Price to $12

Moomoo NewsJul 26 07:38 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Morphic Holding (MORF), Pyxis Oncology (PYXS) and Zynex (ZYXI)

TipRanksJul 26 06:57 ET

H.C. Wainwright Maintains Zynex(ZYXI.US) With Buy Rating, Cuts Target Price to $16

Moomoo NewsJul 26 06:31 ET

Buy Rating Affirmed for Zynex Amid Growth and Strategic Innovations

TipRanksJul 26 06:23 ET

Zynex Analyst Ratings

BenzingaJun 14 10:09 ET

RBC Capital Reiterates Outperform on Zynex, Maintains $15 Price Target

BenzingaJun 14 10:09 ET

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Exelixis (EXEL) and Zynex (ZYXI)

TipRanksMay 1 06:50 ET

RBC Capital Reaffirms Their Buy Rating on Zynex (ZYXI)

TipRanksMay 1 06:45 ET

Zynex Analyst Ratings

BenzingaMay 1 06:36 ET